Attention deficit hyperactivity disorder - A review for family physicians

Indian Journal of Medical Sciences

Volumn 59, Issue 12, 2005, Pages 546-555

  Karande, S ^a  

^a LOKMANYA TILAK MUNICIPAL MEDICAL COLLEGE AND GENERAL HOSPITAL   (India)

Author keywords

Attention deficit hyperactivity disorder; Family physicians; Primary care

Indexed keywords

AMFEBUTAMONE; ANTIHYPERTENSIVE AGENT; ATOMOXETINE; CLONIDINE; DESIPRAMINE; GUANFACINE; METHYLPHENIDATE; PEMOLINE;

ACADEMIC ACHIEVEMENT; ANOREXIA; APPETITE DISORDER; ARTICLE; ATTENTION DEFICIT DISORDER; BEHAVIOR THERAPY; CLINICAL FEATURE; COMORBIDITY; COUNSELING; DRUG EFFICACY; DYSPEPSIA; EARLY DIAGNOSIS; GENERAL PRACTITIONER; GROWTH INHIBITION; HEADACHE; HUMAN; IRRITABILITY; LIVER TOXICITY; MEDICAL DOCUMENTATION; NAUSEA; PARENT; PRESCRIPTION; PREVALENCE; PSYCHOEDUCATION; PSYCHOSOCIAL DEVELOPMENT; SCHOOL; SIDE EFFECT; SLEEP DISORDER; STATISTICAL SIGNIFICANCE; STOMACH PAIN; SYMPTOM; TEACHER; TIC; TREATMENT OUTCOME; VOMITING; WEIGHT REDUCTION;

EID: 29844451691     PISSN: 00195359     EISSN: None     Source Type: Journal    
DOI: 10.4103/0019-5359.19200     Document Type: Article

References (50)

1. Still GF. The Goulstonian lectures on some abnormal psychical conditions in children. Lancet 1902;1:1008-12, 1077-82, 1163-8.
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 2nd ed. Washington, DC: American Psychiatric Association; 1968.
3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 3rd ed. Washington, DC: American Psychiatric Association; 1980.
4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: American Psychiatric Association; 1994.
5. American Academy of Pediatrics. Clinical practice guideline: diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. Pediatrics 2000;105:1158-70.
6. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. rev. Washington, DC: American Psychiatric Association; 2000.
7. Brown RT, Freeman WS, Perrin JM, Stein MT, Amler RW, Feldman HM, et al. Prevalence and assessment of attention-deficit/hyperactivity disorder in primary care settings. Pediatrics 2001;107:e43.
8. Wolraich M, Hannah JN, Baumgaertel A, Pinnock TY, Feurer I. Examination of DSM-IV criteria for attention deficit/hyperactivity disorder in a countywide sample. J Dev Behav Pediatr 1998;19:162-8.
9. Malhi P, Singhi P. Spectrum of attention deficit hyperactivity disorders in children among referrals to psychology services. Indian Pediatr 2000;37:1256-60.
10. Mukhopadhyay M, Misra S, Mitra T, Niyogi P. Attention deficit hyperactivity disorder. Indian J Pediatr 2003;70:789-92.
11. Vaidya CJ, Austin G, Kirkorian G, Ridlehuber HW, Desmond JE, Glover GH, et al. Selective effects of methylphenidate in attention deficit hyperactivity disorder: a functional magnetic resonance study. Proc Natl Acad Sci U S A 1998;24;95:14494-9.
12. Giedd JN, Blumenthal J, Molloy E, Castellanos FX. Brain imaging of attention deficit/hyperactivity disorder. Ann N Y Acad Sci 2001;931:33-49.
13. Pliszka SR, McCracken JT, Maas JW. Catecholamines in attention-deficit hyperactivity disorder: current perspectives. J Am Acad Child Adolesc Psychiatry 1996;35:264-72.
14. Waldman ID, Rowe DC, Abramowitz A, Kozel ST Mohr JH, Sherman SL, et al. Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: heterogeneity owing to diagnostic subtype and severity. Am J Hum Genet 1998;63:1767-76.
15. Barr CL, Wigg KG, Bloom S, Schachar R, Tannock R, Roberts W, et al. Further evidence from haplotype analysis for linkage of the dopamine D4 receptor gene and attention-deficit hyperactivity disorder. Am J Med Genet 2000;96:262-7.
16. Bakker SC, van der Meulen EM, Buitelaar JK, Sandkuijl LA, Pauls DL, Monsuur AJ, et al. A whole-genome scan in 164 Dutch sib pairs with attention-deficit/hyperactivity disorder: suggestive evidence for linkage on chromosomes 7p and 15q. Am J Hum Genet 2003;72:1251-60.
17. Mick E, Biederman J, Prince J, Fischer MJ, Faraone SV. Impact of low birth weight on attention-deficit hyperactivity disorder. J Dev Behav Pediatr 2002;23:16-22.
18. Biederman J, Milberger S, Faraone SV, Kiely K, Guite J, Mick E, et al. Impact of adversity on functioning and comorbidity in children with attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 1995;34:1495-503.
19. Mick E, Biederman J, Faraone SV, Sayer J, Kleinman S. Case-control study of attention-deficit hyperactivity disorder and maternal smoking, alcohol use, and drug use during pregnancy. J Am Acad Child Adolesc Psychiatry 2002;41:378-85.
20. Linnet KM, Dalsgaard S, Obel C, Wisborg K, Henriksen TB, Rodriguez A, et al. Maternal lifestyle factors in pregnancy risk of attention deficit hyperactivity disorder and associated behaviors: review of the current evidence. Am J Psychiatry 2003;160:1028-10.
21. Pliszka SR. Patterns of psychiatric comorbidity with attention-deficit/ hyperactivity disorder. Child Adolesc Psychiatr Clin N Am 2000;9:525-40, vii.
22. Busch B, Biederman J, Cohen LG, Sayer JM, Monuteaux MC, Mick E, et al. Correlates of ADHD among children in pediatric and psychiatric clinics. Psychiatr Serv 2002;53:1103-11.
23. Achenbach TM. Manual for the Child Behavior Checklist/4-18 and the 1991 Profile. Burlington, VT: University of Vermont, Department of Psychiatry; 1991.
24. Biederman J, Faraone SV, Doyle A, Lehman BK, Kraus I, Perrin J, Tsuang MT. Convergence of the Child Behavior Checklist with structured interview-based psychiatric diagnoses of ADHD children with and without comorbidity. J Child Psychol Psychiatry 1993;34:1241-51.
25. Biederman J, Monuteaux MC, Greene RW, Braaten E, Doyle AE, Faraone SV. Long- term stability of the Child Behavior Checklist in a clinical sample of youth with attention deficit hyperactivity disorder. J Clin Child Psychol 2001;30:492-502.
26. Kulkarni M, Kalantre S, Upadhye S, Karande S, Ahuja S. Approach to learning disability. Indian J Pediatr 2001;68:539-46.
27. Biederman J, Mick E, Faraone SV, Braaten E, Doyle A, Spencer T, et al. Influence of gender on attention deficit hyperactivity disorder in children referred to a psychiatric clinic. Am J Psychiatry 2002;159:36-42.
28. Johnston C, Mash EJ. Families of children with attention-deficit/ hyperactivity disorder: review and recommendations for future research. Clin Child Fam Psychol Rev 2001;4:183-207.
29. DuPaul GJ, McGoey KE, Eckert TL, VanBrakle J. Preschool children with attention- deficit/hyperactivity disorder: impairments in behavioral, social, and school functioning. J Am Acad Child Adolesc Psychiatry 2001;40:508-15.
30. Mannuzza S, Klein RG. Long-term prognosis in attention-deficit/ hyperactivity disorder. Child Adolesc Psychiatr Clin N Am 2000;9:711-26.
31. Mannuzza S, Klein RG, Bessler A, Malloy P, LaPadula M. Adult psychiatric status of hyperactive boys grown up. Am J Psychiatry 1998;155:493-8.
32. Bagwell CL, Molina BS, Pelham WE Jr, Hoza B. Attention-deficit hyperactivity disorder and problems in peer relations: predictions from childhood to adolescence. J Am Acad Child Adolesc Psychiatry 2001;40:1285-92.
33. Mannuzza S, Klein RG, Moulton JL 3rd. Persistence of attention deficit/hyperactivity disorder into adulthood: what have we learned from the prospective follow-up studies? J Atten Disord 2003;7:93-100.
34. Brent DA, Perper JA, Goldstein CE, Kolko DJ, Zelenak JP Risk factors for adolescent suicide: a comparison of adolescent suicide victims with suicidal inpatients. Arch Gen Psychiatry 1988;45:581-8.
35. Waxmonsky J. Assessment and treatment of attention deficit hyperactivity disorder in children with comorbid psychiatric illness. Curr Opin Pediatr 2003;15:476-82.
36. The MTA Cooperative Group. A 14-month randomised clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 1999;56:1073-86.
37. Schachter HM, Pham B, King J, Langford S, Moher D. How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis. CMAJ 2001;165:1475-88.
38. Reeves G, Schweitzer J. Pharmacological management of attention-deficit hyperactivity disorder. Expert Opin Pharmacother 2004;5:1313-20.
39. Kratochvil CJ, Vaughan BS, Harrington MJ, Burke WJ. Atomoxetine: a selective noradrenaline reuptake inhibitor for the treatment of attention-deficit/hyperactivity disorder. Expert Opin Pharmacother 2003;4:1165-74.
40. Christman AK, Fermo JD, Markowitz JS. Atomoxetine, a novel treatment for attention-deficit-hyperactivity disorder. Pharmacotherapy 2004;24:1020-36.
41. Pelham WE Jr, Fabiano GA. Behavior modification. Child Adolesc Psychiatr Clin N Am 2000;9:671-88, ix.
42. Sonuga-Barke EJ, Daley D, Thompson M, Laver-Bradbury C, Weeks A. Parent-based therapies for preschool attention-deficit/hyperactivity disorder: a randomized, controlled trial with a community sample. J Am Acad Child Adolesc Psychiatry 2001;40:402-8.
43. Hoffman JB, DuPaul GJ. Psychoeducational interventions for children and adolescents with attention-deficit/hyperactivity disorder. Child Adolesc Psychiatr Clin N Am 2000;9:647-61, ix.
44. Dakin KE. Educational assessment and remediation of learning disabilities. Semin Neurol 1991;11:42-9.
45. Abikoff H, Gittelman R. Hyperactive children treated with stimulants: is cognitive training a useful adjunct? Arch Gen Psychiatry 1985;42:953-61.
46. Wender EH. The food additive-free diet in the treatment of behavior disorders: a review. J Dev Behav Pediatr 1986;7:35-42.
47. Pelham WE Jr, Wheeler T, Chronis A. Empirically supported psychosocial treatments for attention deficit hyperactivity disorder. J Clin Child Psychol 1998;27:190-205.
48. Elia J, Ambrosini PJ, Rapoport JL. Treatment of attention-deficit hyperactivity disorder. N Engl J Med 1999;340:780-8.
49. Voigt RG, Llorente AM, Jensen CL, Fraley JK, Berretta MC, Heird WC. A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyper activity disorder. J Pediatr 2001;139:189-96.
50. Chan E. The role of complementary and alternative medicine in attention-deficit hyperactivity disorder, J Dev Behav Pediatr 2002;23 Suppl 1:S37-45.